Treatment Persistence of Infliximab Versus Adalimumab in Ulcerative Colitis: A 16-Year Single-Center Experience / Pouillon, L., Baumann, C., Rousseau, H., Choukour, M., Andrianjafy, C., Danese, S., Peyrin-Biroulet, L.. - In: INFLAMMATORY BOWEL DISEASES. - ISSN 1078-0998. - 25:5(2019), pp. 945-954. [10.1093/ibd/izy322]
Treatment Persistence of Infliximab Versus Adalimumab in Ulcerative Colitis: A 16-Year Single-Center Experience
Danese S;
2019-01-01
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Treatment Persistence of Infliximab Versus Adalimumab in Ulcerative Colitis A 16-Year Single-Center Experience.pdf
solo gestori archivio
Dimensione
1.99 MB
Formato
Adobe PDF
|
1.99 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
